Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
By L. Friberg, M. Rosenqvist, Gregory Y. H. Lip. European Heart Journal, 2012
1,187 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/3568d6bde2fcaa962aa8329b852d26acba7e3e1d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Epidemiology
Citations in the corpus
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “age is one of the most important predictors of both ischaemic stroke and bleeding in AF patients.(386,387) A high bleeding risk score should generally not result in withholding OAC.”
- 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. (2017, methodology): “(Bottom) The ischemic stroke rates of nonvalvular atrial fibrillation patients are shown as a function of the baseline CHA2DS2-VASc score using 2 large population databases (11,12).”
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. (2012, methodology): “Similar observations were reported in a much larger dataset by Friberg et al.,63 where the adjusted net clinical benefit favoured anticoagulation for almost all AF patients, with the exception of patients at very low risk of ischaemic stroke, with a CHA2DS2-VASc score of 0 and moderate–high bleeding”
- 2018 ESC/EACTS Guidelines on myocardial revascularization. (2019, neutral): “Long-term anticoagulation should be considered in patients with AF after CABG or PCI who are at risk of stroke, considering the individual stroke and bleeding risk.(440,441) IIa B”
- Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report (2012, background): “In Asian countries,(292) PADmay confer an ischemic stroke risk that is much higher than that seen in Western populations.(38)”